Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-3112914374245412024-12-312024-01-01falseNo description of principal activity22truefalseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false OC424799 2024-01-01 2024-12-31 OC424799 2023-01-01 2023-12-31 OC424799 2024-12-31 OC424799 2023-12-31 OC424799 c:CurrentFinancialInstruments 2024-12-31 OC424799 c:CurrentFinancialInstruments 2023-12-31 OC424799 c:CurrentFinancialInstruments 2 2024-12-31 OC424799 c:CurrentFinancialInstruments 2 2023-12-31 OC424799 c:Non-currentFinancialInstruments 2024-12-31 OC424799 c:Non-currentFinancialInstruments 2023-12-31 OC424799 c:CurrentFinancialInstruments c:WithinOneYear 2024-12-31 OC424799 c:CurrentFinancialInstruments c:WithinOneYear 2023-12-31 OC424799 e:FRS102 2024-01-01 2024-12-31 OC424799 e:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 OC424799 e:FullAccounts 2024-01-01 2024-12-31 OC424799 e:LimitedLiabilityPartnershipLLP 2024-01-01 2024-12-31 OC424799 2 2024-01-01 2024-12-31 OC424799 e:PartnerLLP1 2024-01-01 2024-12-31 OC424799 e:PartnerLLP2 2024-01-01 2024-12-31 OC424799 c:OtherCapitalInstrumentsClassifiedAsEquity 2024-12-31 OC424799 c:OtherCapitalInstrumentsClassifiedAsEquity 2023-12-31 OC424799 c:FurtherSpecificReserve2ComponentTotalEquity 2024-12-31 OC424799 c:FurtherSpecificReserve2ComponentTotalEquity 2023-12-31 OC424799 f:PoundSterling 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure

Registered number: OC424799










ASI LONDON C CLINICIAN LLP








UNAUDITED

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2024

 
ASI LONDON C CLINICIAN LLP
 

INFORMATION




Designated Members

ASI London C Holdings Limited
A K Chadwick-Jones

LLP registered number

OC424799

Registered office

1 Welbeck StreetLondonW1G 0AR

Accountants

MHAVictoria Court17-21 Ashford RoadMaidstoneKentME14 5DA


 
ASI LONDON C CLINICIAN LLP
 

CONTENTS



Page
Members' Report
 
 
1 - 2
Accountants' Report
 
 
3
Statement of Comprehensive Income
 
 
4
Balance Sheet
 
 
5 - 6
Reconciliation of Members' Interests
 
 
8
Notes to the Financial Statements
 
 
9 - 13


 
ASI LONDON C CLINICIAN LLP
 
  
MEMBERS' REPORT
FOR THE YEAR ENDED 31 DECEMBER 2024

The members present their annual report together with the financial statements of ASI London C Clinician LLP (the "LLP") for the ended 31 December 2024
 

Principal activities
 
 
The principal activity of the LLP is that of investing activities.
 
 
Designated Members
 
 
ASI London C Holdings Limited and A K Chadwick-Jones were designated members of the LLP throughout the year. 
 

 
Members' capital and interests
 
 
Each member's subscription to the capital of the LLP is determined by their share of the profit and is repayable following retirement from the LLP.
 
 
Details of changes in members' capital in the ended 31 December 2024 are set out in the Reconciliation of Members' Interests.
 
 
Members are remunerated from the profits of the LLP and are required to make their own provision for pensions and other benefits. Profits are allocated and divided between members after finalisation of the financial statements. Members draw a proportion of their profit shares monthly during the year in which it is made, with the balance of profits being distributed after the year, subject to the cash requirements of the business.
 

Members' responsibilities statement
 
 
The members are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
 
 
Company law, (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008), requires the members to prepare financial statements for each financial year. Under that law the members have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) the members must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the LLP and of the profit or loss of the LLP for that period.

In preparing these financial statements, the members are required to:
 
select suitable accounting policies and then apply them consistently;
 
make judgements and accounting estimates that are reasonable and prudent;
 
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the LLP will continue in business.
 

Page 1

 
ASI LONDON C CLINICIAN LLP
 
 
MEMBERS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
 
 
The members are responsible for keeping adequate accounting records that are sufficient to show and explain the LLP's transactions and disclose with reasonable accuracy at any time the financial position of the LLP and to enable them to ensure that the financial statements comply with the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of the Companies Act 2006) Regulations 2008)They are also responsible for safeguarding the assets of the LLP and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
 
This report was approved by the members and signed on their behalf by: 




A K Chadwick-Jones
Designated member


Date: 25 September 2025

Page 2

 
ASI LONDON C CLINICIAN LLP
 
 
  
CHARTERED ACCOUNTANTS' REPORT TO THE MEMBERS ON THE PREPARATION OF THE UNAUDITED STATUTORY FINANCIAL STATEMENTS OF ASI LONDON C CLINICIAN LLP
FOR THE YEAR ENDED 31 DECEMBER 2024

In order to assist you to fulfil your duties under the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008), we have prepared for your approval the financial statements of ASI London C Clinician LLP for the year ended 31 December 2024 which comprise the Statement of Comprehensive Income, the Balance Sheet and the related notes from the LLP's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the members in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of ASI London C Clinician LLP and state those matters that we have agreed to state to the ASI London C Clinician LLP's members in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than ASI London C Clinician LLP and its members for our work or for this report. 

It is your duty to ensure that ASI London C Clinician LLP has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of ASI London C Clinician LLP. You consider that ASI London C Clinician LLP is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of ASI London C Clinician LLP. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



MHA
Chartered Accountants
Victoria Court
17-21 Ashford Road
Maidstone
Kent
ME14 5DA
30 September 2025
Page 3

 
ASI LONDON C CLINICIAN LLP
 
 
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024

2024
2023
£
£

  

Administrative expenses
  
(4,613)
(4,209)

Operating loss
  
 
(4,613)
 
(4,209)

Income from participating interests
  
1,296,050
428,750

Interest receivable and similar income
  
45,132
57,393

Profit before tax
  
 
1,336,569
 
481,934

Profit for the year before members' remuneration and profit shares
  
 
1,336,569
 
481,934

Profit for the year before members' remuneration and profit shares
  
1,336,569
481,934

Members' remuneration charged as an expense
  
(45,132)
(57,393)

Profit for the financial year available for discretionary division among members
  
 
1,291,437
 
424,541

There were no recognised gains and losses for 2024 or 2023 other than those included in the statement of comprehensive income.

There was no other comprehensive income for 2024(2023:£NIL).

The notes on pages 9 to 13 form part of these financial statements.

Page 4

 
ASI LONDON C CLINICIAN LLP
REGISTERED NUMBER: OC424799

BALANCE SHEET
AS AT 31 DECEMBER 2024

2024
2023
Note
£
£

Fixed assets
  

Investments
 5 
305,432
186,859

Current assets
  

Debtors: amounts falling due after more than one year
 6 
234,806
476,121

Debtors: amounts falling due within one year
 6 
1,954,960
840,149

Cash at bank and in hand
  
12,887
88,876

  
2,202,653
1,405,146

Creditors: Amounts Falling Due Within One Year
 7 
(9,482)
(10,247)

Net current assets
  
 
 
2,193,171
 
 
1,394,899

Total assets less current liabilities
  
2,498,603
1,581,758

  

Net assets
  
2,498,603
1,581,758


Represented by:
  

Loans and other debts due to members within one year
  

Members' capital classified as a liability
  
560,479
758,042

Members' other interests
  

Members' capital classified as equity
  
646,687
399,175

Other reserves classified as equity
  
1,291,437
424,541

  
 
1,938,124
 
823,716

  
2,498,603
1,581,758


Total members' interests
  

Amounts due from members (included in debtors)
 6 
(1,705,401)
(590,590)

Loans and other debts due to members
 8 
560,479
758,042

Members' other interests
  
1,938,124
823,716

  
793,202
991,168


Page 5

 
ASI LONDON C CLINICIAN LLP
REGISTERED NUMBER: OC424799
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2024

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small LLPs regime.

The entity was entitled to exemption from audit under section 477 of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008.

The members acknowledge their responsibilities for complying with the requirements of the Companies Act 2006, as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008, with respect to accounting records and the preparation of financial statements.

The financial statements were approved and authorised for issue by the members and were signed on their behalf by: 



A K Chadwick-Jones
Designated member

Date: 25 September 2025

The notes on pages 9 to 13 form part of these financial statements.

Page 6

 
ASI LONDON C CLINICIAN LLP
 

RECONCILIATION OF MEMBERS' INTERESTS
FOR THE YEAR ENDED 31 DECEMBER 2024








EQUITY
Members' other interests
DEBT
Loans and other debts due to members less any amounts due from members in debtors
Total members' interests
Members' capital (classified as equity)
Other reserves
Total
Members' capital (classified as debt)
Other amounts
Total
Total

£
£
£
£
£
£
£

Amounts due to members 
1,100,938
-
1,100,938


Amounts due from members 

(98,000)
(98,000)


Balance at 1 January 2023 
424,568
93,662
518,230
1,100,938
(98,000)
1,002,938
1,521,168

Profit for the year available for discretionary division among members
 
-
424,541
424,541
-
-
-
424,541

Members' interests after profit for the year
424,568
518,203
942,771
1,100,938
(98,000)
1,002,938
1,945,709

Other division of profits
-
(93,662)
(93,662)
53,055
98,000
151,055
57,393

Amounts introduced by members
50,475
-
50,475
26,108
-
26,108
76,583

Repayment of capital and members' remuneration
(75,868)
-
(75,868)
(422,059)
-
(422,059)
(497,927)

Drawings on account and distribution of profit
-
-
-
-
(590,590)
(590,590)
(590,590)

Amounts due to members
758,042
-
758,042

Amounts due from members
 




(590,590)
(590,590)

Page 7

 
ASI LONDON C CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

RECONCILIATION OF MEMBERS' INTERESTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024


Balance at 31 December 2023
399,175
424,541
823,716
758,042
(590,590)
167,452
991,168

Profit for the year available for discretionary division among members
 
-
1,291,437
1,291,437
-
-
-
1,291,437

Members' interests after profit for the year
399,175
1,715,978
2,115,153
758,042
(590,590)
167,452
2,282,605

Other division of profits
-
(424,541)
(424,541)
40,923
428,750
469,673
45,132

Amounts introduced by members
468,050
-
468,050
127,577
-
127,577
595,627

Repayment of capital and members' remuneration
(220,538)
-
(220,538)
(366,063)
-
(366,063)
(586,601)

Drawings on account and distribution of profit
-
-
-
-
(1,543,561)
(1,543,561)
(1,543,561)

Amounts due to members
560,479
-
560,479

Amounts due from members
 




(1,705,401)
(1,705,401)


Balance at 31 December 2024 
646,687
1,291,437
1,938,124
560,479
(1,705,401)
(1,144,922)
793,202

There are no existing restrictions or limitations which impact the ability of the members of the LLP to reduce the amount of Members' other interests.

Page 8

 
ASI LONDON C CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


General information

ASI London C Clinician LLP is a Limited Liability Partnership in England and Wales in the United Kingdom. The address of the registered office is 1 Welbeck Street, London, W1G 0AR.
The financial statements are presented in sterling which is the functional currency of the LLP and rounded to the nearest £1. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires management to exercise judgement in applying the LLP's accounting policies (see note 3).

The following principal accounting policies have been applied:

 
2.2

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.3

Division and distribution of profits

A division of profits is the mechanism by which the profits of an LLP become a debt due to members. A division may be automatic or discretionary, may relate to some or all of the profits for a financial period and may take place during or after the end of a financial period.

An automatic division of profits is one where the LLP does not have an unconditional right to avoid making a division of an amount of profits based on the members' agreement in force at the time, whereas a discretionary division of profits requires a decision to be made by the LLP, which it has the unconditional right to avoid making.

The LLP divides profits both automatically and discretionarily. Automatic divisions of profits are recognised as 'Members' remuneration charged as an expense' in the Statement of comprehensive income. Discretionary divisions of profits are recognised as amounts due to members, although may be used to offset amounts which have been drawn by members, which are recognised as loan assets repayable.

 
2.4

Associates and joint ventures

Associates and Joint Ventures are held at cost less impairment.

Page 9

 
ASI LONDON C CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)

 
2.5

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.6

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.7

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.8

Financial instruments

The LLP has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the LLP's Balance Sheet when the LLP becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The LLP's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the LLP after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Page 10

 
ASI LONDON C CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.Accounting policies (continued)


2.8
Financial instruments (continued)

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.


3.


Judgements in applying accounting policies and key sources of estimation uncertainty

No significant judgements have been made by management in preparing these financial statements, other than those disclosed in note 2 above.


4.


Employees

The average monthly number of employees during the year was 0 (2023 - 0).


5.


Fixed asset investments





Investments in joint ventures

£



Cost or valuation


At 1 January 2024
186,859


Additions
118,573



At 31 December 2024
305,432




Page 11

 
ASI LONDON C CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

6.


Debtors

2024
2023
£
£

Due after more than one year

Due from participating interests
234,806
476,121


2024
2023
£
£

Due within one year

Amounts owed by joint ventures and associated undertakings
249,559
249,559

Amounts due from members
1,705,401
590,590

1,954,960
840,149



7.


Creditors: Amounts falling due within one year

2024
2023
£
£

Trade creditors
-
1,077

Other creditors
5,030
5,030

Accruals and deferred income
4,452
4,140

9,482
10,247


Page 12

 
ASI LONDON C CLINICIAN LLP
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

8.


Loans and other debts due to members


2024
2023
£
£



Members' capital treated as debt
560,479
758,042

Loans and other debts due to members may be further analysed as follows:

2024
2023
£
£



Falling due within one year
249,559
249,559

Falling due after more than one year
310,920
508,483

560,479
758,042

Loans and other debts due to members rank equally with debts due to ordinary creditors in the event of a winding up.

Page 13